Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.
about
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoproteinElicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoproteinHIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine developmentBreadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigsEmerging nanotechnology approaches for HIV/AIDS treatment and prevention.An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys.A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine designHIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost.Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLModulation of HIV-1 immunity by adjuvants.Role of adjuvants in modeling the immune response.Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
P2860
Q28730561-33CFA1C8-9D6B-4BEE-8682-AE5C07B3D1F2Q28732438-8FECA5BF-75D0-4CA6-B286-035974EEDCE3Q30355260-F55E9668-48F4-40E1-B409-19405A8EBEA6Q33725679-EDF3DACE-0A64-490B-AE00-4C93393C2862Q33819656-EF52F9A8-C6B6-4FAD-B14A-AA340998B942Q33820645-F023A9FD-7522-4EAB-9DCB-B8F16D0343CEQ33901007-83F1D7BD-1D4F-4DA2-8A47-7DC6B676270EQ34189785-CA6D2D30-7896-4384-BF93-57BE16D4777BQ34743297-E361586B-2FD1-4505-B646-07BBF5FE8B72Q35076748-B3B8221B-27C2-48A1-876D-21E5AF3D8018Q35196671-F74B5630-05EB-4E89-A747-5DF7ABFF333AQ35883997-AE073BB4-5841-4100-A532-2616F34BA842Q35913910-60383BA2-5DC9-460E-8D0B-816BA7D13B1CQ37698564-9028FA4E-28CE-4B96-8EE4-5760E0D49F2AQ37803320-2CB50699-42AE-418D-8432-BBD995FD6B15Q37812128-6E562DFF-0E7F-4DB0-8BF2-F58BFBCF6652
P2860
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Neutralizing antibody response ...... rotein vaccination in rabbits.
@en
type
label
Neutralizing antibody response ...... rotein vaccination in rabbits.
@en
prefLabel
Neutralizing antibody response ...... rotein vaccination in rabbits.
@en
P2093
P2860
P1433
P1476
Neutralizing antibody response ...... rotein vaccination in rabbits.
@en
P2093
Brian Burke
Elaine Kan
Indresh K Srivastava
Jeffrey Ulmer
Susan W Barnett
Victor Raúl Gómez-Román
P2860
P304
P356
10.1016/J.VIROL.2009.02.005
P407
P577
2009-02-27T00:00:00Z